{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:19:56Z","timestamp":1790363996088,"version":"4.1.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jid.2021.11.018","type":"journal-article","created":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T12:44:23Z","timestamp":1642077863000},"page":"944-950","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"PB","title":["Applying Early Intervention Strategies to Autoimmune Skin Diseases. Is the Window of Opportunity Preclinical? A Dermato-Rheumatology Perspective"],"prefix":"10.1016","volume":"142","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8724-5937","authenticated-orcid":false,"given":"Lucy M.","family":"Carter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7715-8226","authenticated-orcid":false,"given":"Dennis","family":"McGonagle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1637-4755","authenticated-orcid":false,"given":"Edward M.","family":"Vital","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2328-4926","authenticated-orcid":false,"given":"Miriam","family":"Wittmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2021.11.018_bib1","article-title":"Treating the skin with biologics in patients with psoriasis decreases the incidence of psoriatic arthritis [e-pub ahead of print]","author":"Acosta Felquer","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2021.11.018_bib2","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1136\/annrheumdis-2015-208324","article-title":"Optimisation of a treat-to-target approach in rheumatoid arthritis: strategies for the 3-month time point","volume":"75","author":"Aletaha","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2021.11.018_bib3","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1186\/s13063-019-3403-7","article-title":"Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study): a multi-centre, randomised, double-blind, parallel-group, placebo-controlled clinical trial protocol","volume":"20","author":"Al-Laith","year":"2019","journal-title":"Trials"},{"key":"10.1016\/j.jid.2021.11.018_bib4","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus","volume":"349","author":"Arbuckle","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2021.11.018_bib5","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1136\/ard.2008.105759","article-title":"Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort study","volume":"69","author":"Bos","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2021.11.018_bib6","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/BOR.0000000000000199","article-title":"Preclinical lupus","volume":"27","author":"Bourn","year":"2015","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jid.2021.11.018_bib7","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/bjd.18482","article-title":"Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid-sparing effect","volume":"182","author":"Chen","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2021.11.018_bib8","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1136\/annrheumdis-2020-216972","article-title":"Dysbiosis in the oral microbiomes of anti-CCP positive individuals at risk of developing rheumatoid arthritis","volume":"80","author":"Cheng","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2021.11.018_bib9","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/art.38628","article-title":"Modular transcriptional repertoire analyses of adults with systemic lupus erythematosus reveal distinct type I and type II interferon signatures","volume":"66","author":"Chiche","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jid.2021.11.018_bib10","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1016\/S0140-6736(15)00347-5","article-title":"Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial","volume":"386","author":"Coates","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jid.2021.11.018_bib11","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/art.10747","article-title":"Elucidation of the relationship between synovitis and bone damage: a randomized magnetic resonance imaging study of individual joints in patients with early rheumatoid arthritis","volume":"48","author":"Conaghan","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2021.11.018_bib12","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nrrheum.2010.176","article-title":"Genetic susceptibility to systemic lupus erythematosus in the genomic era","volume":"6","author":"Deng","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jid.2021.11.018_bib13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11926-020-00911-w","article-title":"The role of musculoskeletal ultrasound in the rheumatoid arthritis continuum","volume":"22","author":"Di Matteo","year":"2020","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.jid.2021.11.018_bib14","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1136\/annrheumdis-2020-217215","article-title":"Ultrasound erosions in the feet best predict progression to inflammatory arthritis in anti-CCP positive at-risk individuals without clinical synovitis","volume":"79","author":"Di Matteo","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2021.11.018_bib15","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/jid.2012.418","article-title":"Streptococcus induces circulating CLA(+) memory T-cell-dependent epidermal cell activation in psoriasis","volume":"133","author":"Ferran","year":"2013","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2021.11.018_bib16","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/aje\/kwn380","article-title":"Prospects for epigenetic epidemiology [published correction appears in Am J Epidemiol 2009;169:1409","volume":"169","author":"Foley","year":"2009","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jid.2021.11.018_bib17","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.immuni.2011.11.018","article-title":"Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease","volume":"36","author":"Gall","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.jid.2021.11.018_bib18","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/annrheumdis-2017-212763","article-title":"Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis: the PRAIRI study","volume":"78","author":"Gerlag","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2021.11.018_bib19","article-title":"Biological disease-modifying antirheumatic drugs may mitigate the risk of psoriatic arthritis in patients with chronic plaque psoriasis [e-pub ahead of print]","author":"Gisondi","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2021.11.018_bib20","first-page":"279","article-title":"Prevalence of psoriatic arthritis and joint complaints in a large population of Italian patients hospitalised for psoriasis","volume":"15","author":"Gisondi","year":"2005","journal-title":"Eur J Dermatol"},{"issue":"Suppl. 2","key":"10.1016\/j.jid.2021.11.018_bib21","doi-asserted-by":"crossref","first-page":"ii14","DOI":"10.1136\/ard.2004.032482","article-title":"Psoriatic arthritis: epidemiology, clinical features, course, and outcome","volume":"64","author":"Gladman","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2021.11.018_bib22","first-page":"1955","article-title":"Accrual of organ damage over time in patients with systemic lupus erythematosus","volume":"30","author":"Gladman","year":"2003","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.jid.2021.11.018_bib23","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1002\/1529-0131(199910)42:10<2184::AID-ANR20>3.0.CO;2-2","article-title":"Persistence of mild, early inflammatory arthritis: the importance of disease duration, rheumatoid factor, and the shared epitope","volume":"42","author":"Green","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2021.11.018_bib24","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(04)16676-2","article-title":"Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial","volume":"364","author":"Grigor","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jid.2021.11.018_bib25","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s41927-019-0054-y","article-title":"Real world long-term impact of intensive treatment on disease activity, disability and health-related quality of life in rheumatoid arthritis","volume":"3","author":"Gullick","year":"2019","journal-title":"BMC Rheumatol"},{"key":"10.1016\/j.jid.2021.11.018_bib26","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1002\/art.22665","article-title":"Clinical criteria for systemic lupus erythematosus precede diagnosis, and associated autoantibodies are present before clinical symptoms","volume":"56","author":"Heinlen","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2021.11.018_bib27","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0140-6736(20)32341-2","article-title":"Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial","volume":"397","author":"Humby","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jid.2021.11.018_bib28","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1111\/jdv.14979","article-title":"Secukinumab treatment in new-onset psoriasis: aiming to understand the potential for disease modification - rationale and design of the randomized, multicenter STEPIn study","volume":"32","author":"Iversen","year":"2018","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2021.11.018_bib29","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/jid.2013.269","article-title":"Dominant Th1 and minimal Th17 skewing in discoid lupus revealed by transcriptomic comparison with psoriasis [published correction appears in J Invest Dermatol 2014;134:1780","volume":"134","author":"Jabbari","year":"2014","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2021.11.018_bib30","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/0961203307078579","article-title":"Hydroxychloroquine sulfate treatment is associated with later onset of systemic lupus erythematosus","volume":"16","author":"James","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.jid.2021.11.018_bib31","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1136\/ard.2010.141234","article-title":"The impact of four dynamic, goal-steered treatment strategies on the 5-year outcomes of rheumatoid arthritis patients in the BeSt study","volume":"70","author":"Klarenbeek","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2021.11.018_bib32","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jaad.2020.08.028","article-title":"Network meta-analysis-based comparison of first-line steroid-sparing adjuvants in treatment of pemphigus vulgaris and pemphigus foliaceus","volume":"85","author":"Lee","year":"2021","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2021.11.018_bib33","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/art.41652","article-title":"Tissue-resident memory CD8+ T cells from skin differentiate psoriatic arthritis from psoriasis","volume":"73","author":"Leijten","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jid.2021.11.018_bib34","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.immuni.2018.03.020","article-title":"Self-renewal and toll-like receptor signaling sustain exhausted plasmacytoid dendritic cells during chronic viral infection","volume":"48","author":"Macal","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.jid.2021.11.018_bib35","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.5394","article-title":"Prevalence of periodontal disease and periodontopathic bacteria in anti\u2013cyclic citrullinated protein antibody\u2013positive at-risk adults without arthritis","volume":"2","author":"Mankia","year":"2019","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.jid.2021.11.018_bib36","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/art.39603","article-title":"Preclinical rheumatoid arthritis: progress toward prevention","volume":"68","author":"Mankia","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jid.2021.11.018_bib37","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nm1167","article-title":"Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry","volume":"11","author":"McClain","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.jid.2021.11.018_bib38","article-title":"Does biologic therapy impact the development of PsA among patients with psoriasis? [e-pub ahead of print]","author":"Meer","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2021.11.018_bib39","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.jid.2021.01.005","article-title":"Differential changes in inflammatory mononuclear phagocyte and T-cell profiles within psoriatic skin during treatment with guselkumab vs. secukinumab","volume":"141","author":"Mehta","year":"2021","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2021.11.018_bib40","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2020-000428","article-title":"RNA tape sampling in cutaneous lupus erythematosus discriminates affected from unaffected and healthy volunteer skin","volume":"8","author":"Merola","year":"2021","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.jid.2021.11.018_bib41","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1912196","article-title":"Trial of anifrolumab in active systemic lupus erythematosus","volume":"382","author":"Morand","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2021.11.018_bib42","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/art.10135","article-title":"Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis","volume":"46","author":"M\u00f6tt\u00f6nen","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2021.11.018_bib43","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nature24271","article-title":"Inflammatory memory sensitizes skin epithelial stem cells to tissue damage [published correction appears in Nature 2018;560:E2]","volume":"550","author":"Naik","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jid.2021.11.018_bib44","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1136\/annrheumdis-2015-207871","article-title":"Enriching case selection for imminent RA: the use of anti-CCP antibodies in individuals with new non-specific musculoskeletal symptoms \u2013 a cohort study","volume":"75","author":"Nam","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2021.11.018_bib45","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/rheumatology\/keh199","article-title":"Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis","volume":"43","author":"Nell","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jid.2021.11.018_bib46","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/ard.50.9.637","article-title":"In\u00a0vitro effects of methotrexate on peripheral blood monocytes: modulation by folinic acid and S-adenosylmethionine","volume":"50","author":"Nesher","year":"1991","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2021.11.018_bib47","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.20018","article-title":"Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors","volume":"50","author":"Nielen","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2021.11.018_bib48","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/rheumatology\/kes324","article-title":"Prevalence and treatment patterns of psoriatic arthritis in the UK","volume":"52","author":"Ogdie","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jid.2021.11.018_bib49","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nature21379","article-title":"Survival of tissue-resident memory T cells requires exogenous lipid uptake and metabolism","volume":"543","author":"Pan","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jid.2021.11.018_bib50","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1038\/s41467-020-18513-6","article-title":"Single-cell sequencing reveals clonal expansions of pro-inflammatory synovial CD8 T cells expressing tissue-homing receptors in psoriatic arthritis","volume":"11","author":"Penkava","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jid.2021.11.018_bib51","doi-asserted-by":"crossref","first-page":"6149","DOI":"10.1038\/s41467-020-19918-z","article-title":"Functionally impaired plasmacytoid dendritic cells and non-haematopoietic sources of type I interferon characterize human autoimmunity","volume":"11","author":"Psarras","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jid.2021.11.018_bib52","first-page":"1662","article-title":"Type I interferon-mediated autoimmune diseases: pathogenesis, diagnosis and targeted therapy","volume":"56","author":"Psarras","year":"2017","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl. 31","key":"10.1016\/j.jid.2021.11.018_bib53","first-page":"S154","article-title":"Window of opportunity in early rheumatoid arthritis: possibility of altering the disease process with early intervention","volume":"21","author":"Quinn","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jid.2021.11.018_bib54","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1136\/annrheumdis-2014-205227","article-title":"Predicting the development of clinical arthritis in anti-CCP positive individuals with non-specific musculoskeletal symptoms: a prospective observational cohort study","volume":"74","author":"Rakieh","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2021.11.018_bib55","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1084\/jem.20161451","article-title":"Detection of interferon alpha protein reveals differential levels and cellular sources in disease","volume":"214","author":"Rodero","year":"2017","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jid.2021.11.018_bib56","doi-asserted-by":"crossref","first-page":"F59","DOI":"10.1084\/jem.194.12.f59","article-title":"A\u00a0pivotal role for the natural interferon alpha-producing cells (plasmacytoid dendritic cells) in the pathogenesis of lupus","volume":"194","author":"R\u00f6nnblom","year":"2001","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jid.2021.11.018_bib57","doi-asserted-by":"crossref","first-page":"R109","DOI":"10.1186\/ar2764","article-title":"Predictors of major infections in systemic lupus erythematosus","volume":"11","author":"Ruiz-Irastorza","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jid.2021.11.018_bib58","doi-asserted-by":"crossref","first-page":"652191","DOI":"10.3389\/fimmu.2021.652191","article-title":"Resident memory T cells in autoimmune skin diseases","volume":"12","author":"Ryan","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2021.11.018_bib59","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/art.40778","article-title":"Regression of peripheral subclinical enthesopathy in therapy-naive patients treated with ustekinumab for moderate-to-severe chronic plaque psoriasis: a fifty-two-week, prospective, open-label feasibility study","volume":"71","author":"Savage","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jid.2021.11.018_bib60","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2019-000328","article-title":"Plucked hair follicles from patients with chronic discoid lupus erythematosus show a disease-specific molecular signature","volume":"6","author":"Shalbaf","year":"2019","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.jid.2021.11.018_bib61","article-title":"Psoriatic arthritis incidence among patients receiving biologic medications for psoriasis: a nested case control study [e-pub ahead of print]","author":"Shalev Rosenthal","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jid.2021.11.018_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.39480","article-title":"2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis","volume":"68","author":"Singh","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jid.2021.11.018_bib63","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2019097118","article-title":"Acute skin exposure to ultraviolet light triggers neutrophil-mediated kidney inflammation","volume":"118","author":"Skopelja-Gardner","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2021.11.018_bib64","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1136\/annrheumdis-2019-216655","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update","volume":"79","author":"Smolen","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2021.11.018_bib65","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.4049\/jimmunol.1800650","article-title":"Hypersensitive IFN responses in lupus keratinocytes reveal key mechanistic determinants in cutaneous lupus","volume":"202","author":"Tsoi","year":"2019","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2021.11.018_bib66","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/ard.2010.132662","article-title":"The extent of the anti-citrullinated protein antibody repertoire is associated with arthritis development in patients with seropositive arthralgia","volume":"70","author":"van de Stadt","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2021.11.018_bib67","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1002\/art.27692","article-title":"Long-term impact of delay in assessment of patients with early arthritis","volume":"62","author":"van der Linden","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2021.11.018_bib68","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1136\/ard.2009.124537","article-title":"Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis","volume":"69","author":"van der Woude","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2021.11.018_bib69","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1002\/art.39085","article-title":"Brief report: responses to rituximab suggest B cell-independent inflammation in cutaneous systemic lupus erythematosus","volume":"67","author":"Vital","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jid.2021.11.018_bib70","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jaut.2006.09.001","article-title":"Autoantibody profiling to identify individuals at risk for systemic lupus erythematosus","volume":"27","author":"Wandstrat","year":"2006","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jid.2021.11.018_bib71","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2119\/molmed.2011.00048","article-title":"Low-dose methotrexate inhibits methionine S-adenosyltransferase in\u00a0vitro and in\u00a0vivo","volume":"18","author":"Wang","year":"2012","journal-title":"Mol Med"},{"key":"10.1016\/j.jid.2021.11.018_bib72","doi-asserted-by":"crossref","first-page":"e418","DOI":"10.1016\/S2665-9913(20)30064-3","article-title":"Associations between gut microbiota and genetic risk for rheumatoid arthritis in the absence of disease: a cross-sectional study","volume":"2","author":"Wells","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.jid.2021.11.018_bib73","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41584-019-0272-0","article-title":"Cutaneous lupus erythematosus: new insights into pathogenesis and therapeutic strategies","volume":"15","author":"Wenzel","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jid.2021.11.018_bib74","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1001\/jamadermatol.2013.9026","article-title":"Systemic symptoms in the progression of cutaneous to systemic lupus erythematosus","volume":"150","author":"Wieczorek","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2021.11.018_bib75","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/art.24172","article-title":"Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study [published correction appears in Arthritis Rheum 2010;62:574","volume":"61","author":"Wilson","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2021.11.018_bib76","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1016\/j.jid.2021.02.743","article-title":"New frontiers in psoriatic disease research, part II: comorbidities and targeted therapies","volume":"141","author":"Yan","year":"2021","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2021.11.018_bib77","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1136\/annrheumdis-2018-213386","article-title":"Prediction of autoimmune connective tissue disease in an at-risk cohort: prognostic value of a novel two-score system for interferon status","volume":"77","author":"Md Yusof","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2021.11.018_bib78","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2019-001067","article-title":"Transition phase towards psoriatic arthritis: clinical and ultrasonographic characterisation of psoriatic arthralgia","volume":"5","author":"Zabotti","year":"2019","journal-title":"RMD Open"},{"key":"10.1016\/j.jid.2021.11.018_bib79","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/jid.2010.244","article-title":"Evidence for a pathophysiological role of keratinocyte-derived type III interferon (IFN\u03bb) in cutaneous lupus erythematosus","volume":"131","author":"Zahn","year":"2011","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2021.11.018_bib80","doi-asserted-by":"crossref","first-page":"S174","DOI":"10.1016\/j.jid.2019.03.1080","article-title":"1004 increased tissue-resident memory T (TRM) cells and STAT3 expression in cutaneous lupus erythematosus patients refractory to antimalarials","volume":"139","author":"Zeidi","year":"2019","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2021.11.018_bib81","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/nm.3914","article-title":"The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment","volume":"21","author":"Zhang","year":"2015","journal-title":"Nat Med"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X2102532X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X2102532X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T17:28:35Z","timestamp":1758302915000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X2102532X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":81,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0022202X2102532X"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2021.11.018","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Applying Early Intervention Strategies to Autoimmune Skin Diseases. Is the Window of Opportunity Preclinical? A Dermato-Rheumatology Perspective","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2021.11.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}